Patient characteristics
. | Median . | Range . | Cutoff (patients, %) . |
|---|---|---|---|
| Age, y | 59 | 24-87 | ≥ 65 (32) |
| Age, healthy donors, y | 32 | 21-41 | — |
| β2-microglobulin, mg/L | 3.3 | 1.0-153.4 | ≥ 4.0 (41) |
| C-reactive protein, mg/L | 2.8 | 0.3-101.0 | ≥ 4.0 (60) |
| Hemoglobin level, g/dL | 11.0 | 6.5-15.7 | < 10 (32) |
| Albumin, mg/L | 3.7 | 1.0-5.4 | < 3.5 (33) |
| Lactic acid dehydrogenase, IU/L | 167 | 55-1035 | ≥ 190 (34) |
| PCs in bone marrow, % | 50 | 4-99 | ≥ 50 (52) |
| Platelet count, × 109/L* | 200 | 17-572 | < 150 (25) |
| IL-6, pg/mL, n = 83 patients | 5.7 | < 0.7-227 | ≥ 3.5 (70) |
| Labeling index, %, n = 91 patients | 0.4 | 0-4.6 | ≥ 0.5 (47) |
. | Median . | Range . | Cutoff (patients, %) . |
|---|---|---|---|
| Age, y | 59 | 24-87 | ≥ 65 (32) |
| Age, healthy donors, y | 32 | 21-41 | — |
| β2-microglobulin, mg/L | 3.3 | 1.0-153.4 | ≥ 4.0 (41) |
| C-reactive protein, mg/L | 2.8 | 0.3-101.0 | ≥ 4.0 (60) |
| Hemoglobin level, g/dL | 11.0 | 6.5-15.7 | < 10 (32) |
| Albumin, mg/L | 3.7 | 1.0-5.4 | < 3.5 (33) |
| Lactic acid dehydrogenase, IU/L | 167 | 55-1035 | ≥ 190 (34) |
| PCs in bone marrow, % | 50 | 4-99 | ≥ 50 (52) |
| Platelet count, × 109/L* | 200 | 17-572 | < 150 (25) |
| IL-6, pg/mL, n = 83 patients | 5.7 | < 0.7-227 | ≥ 3.5 (70) |
| Labeling index, %, n = 91 patients | 0.4 | 0-4.6 | ≥ 0.5 (47) |
Total sample, 183 patients. Male patients constituted 66% of sample; and white patients, 85%.
Platelet count was taken at diagnosis.